Works matching IS 19466234 AND DT 2012 AND VI 4 AND IP 120

Results: 5

Escaping ALK Inhibition: Mechanisms of and Strategies to Overcome Resistance.
Published in:
Science Translational Medicine, 2012, v. 4, n. 120, p. 1, doi. 10.1126/scitranslmed.3003728
By:
- Lovly, Christine M.;
- Pao, William
Publication type:
Article
Mechanisms of Acquired Crizotinib Resistance in ALK-Rearranged Lung Cancers.
Published in:
Science Translational Medicine, 2012, v. 4, n. 120, p. 1, doi. 10.1126/scitranslmed.3003316
By:
- Katayama, Ryohei;
- Shaw, Alice T.;
- Khan, Tahsin M.;
- Mino-Kenudson, Mari;
- Solomon, Benjamin J.;
- Halmos, Balazs;
- Jessop, Nicholas A.;
- Wain, John C.;
- Alan Tien Yeo;
- Benes, Cyril;
- Drew, Lisa;
- Saeh, Jamal Carlos;
- Crosby, Katherine;
- Sequist, Lecia V.;
- Iafrate, A. John;
- Engelman, Jeffrey A.
Publication type:
Article
Simultaneous Targeting of Toll- and Nod-Like Receptors Induces Effective Tumor-Specific Immune Responses.
Published in:
Science Translational Medicine, 2012, v. 4, n. 120, p. 1, doi. 10.1126/scitranslmed.3002868
By:
- Garaude, Johan;
- Kent, Andrew;
- van Rooijen, Nico;
- Blander, J. Magarian
Publication type:
Article
Improving Immunotherapy: Revisiting the Immunologist's Little Secret.
Published in:
Science Translational Medicine, 2012, v. 4, n. 120, p. 1, doi. 10.1126/scitranslmed.3003658
By:
- Berzofsky, Jay A.
Publication type:
Article
AAV2 Gene Therapy Readministration in Three Adults with Congenital Blindness.
Published in:
Science Translational Medicine, 2012, v. 4, n. 120, p. 1, doi. 10.1126/scitranslmed.3002865
By:
- Bennett, Jean;
- Ashtari, Manzar;
- Wellman, Jennifer;
- Marshall, Kathleen A.;
- Cyckowski, Laura L.;
- Chung, Daniel C.;
- McCague, Sarah;
- Pierce, Eric A.;
- Yifeng Chen;
- Bennicelli, Jeannette L.;
- Xiaosong Zhu;
- Gui-shuang Ying;
- Junwei Sun;
- Fraser Wright, J.;
- Auricchio, Alberto;
- Simonelli, Francesca;
- Shindler, Kenneth S.;
- Mingozzi, Federico;
- High, Katherine A.;
- Maguire, Albert M.
Publication type:
Article

Works matching IS 19466234 AND DT 2012 AND VI 4 AND IP 120

Escaping ALK Inhibition: Mechanisms of and Strategies to Overcome Resistance.

Mechanisms of Acquired Crizotinib Resistance in ALK-Rearranged Lung Cancers.

Simultaneous Targeting of Toll- and Nod-Like Receptors Induces Effective Tumor-Specific Immune Responses.

Improving Immunotherapy: Revisiting the Immunologist's Little Secret.

AAV2 Gene Therapy Readministration in Three Adults with Congenital Blindness.